The Largest Human Study on Aspartame and Cancer Risk
A large-scale prospective study analyzing data from the Nurses’ Health Study and the Health Professionals Follow-Up Study examined the potential link between aspartame consumption and cancer risk over a 22-year period. The study included 77,218 women and 47,810 men, generating a combined total of 2,278,396 person-years of observational data — making it the longest-running and most comprehensive human study ever conducted on aspartame as a potential carcinogen.
What distinguished this research from earlier studies was the rigor of its dietary assessment methodology. Participants completed detailed dietary questionnaires every two years, and their overall diets were reassessed every four years. Previous studies that found no association between aspartame and cancer had typically assessed participants’ artificial sweetener intake at only a single point in time, a methodological limitation that could significantly affect accuracy in measuring long-term exposure.
Findings: Elevated Cancer Risk With Daily Diet Soda Consumption
The pooled analysis revealed that consumption of just one 12-ounce can of diet soda per day was associated with measurable increases in cancer risk:
- A 42 percent higher risk of leukemia in both men and women
- A 102 percent higher risk of multiple myeloma in men
- A 31 percent higher risk of non-Hodgkin lymphoma in men
These figures were derived from multi-variable relative risk models comparing diet soda consumers to participants who consumed none. The researchers did not establish a clear explanation for why the elevated risks for multiple myeloma and non-Hodgkin lymphoma appeared only in male participants.
Diet soda represented by far the largest dietary source of aspartame in the United States. Annual American consumption of aspartame totaled approximately 5,250 tons, with roughly 86 percent — about 4,500 tons — found in diet sodas.
Consistency With Prior Animal Research
The human study results aligned with findings from what was considered the most rigorous prior animal research on the subject. A 2006 study that followed 900 rats over their entire natural lifespans had found that aspartame significantly increased the risk of lymphomas and leukemia in both males and females.
A subsequent follow-up mega-study, which began aspartame exposure at the fetal stage, confirmed the elevated lymphoma and leukemia risks and additionally found that female rats exhibited significantly increased rates of breast cancer. These animal findings had raised questions about whether long-term, high-quality human studies would eventually reveal similar patterns — questions that the Nurses’ Health Study data appeared to address.
Implications and an Unexpected Finding About Sugar-Sweetened Soda
The study’s methodology addressed the two primary criticisms that had been leveled against previous research showing no aspartame-cancer link: insufficient duration and inaccurate assessment of long-term consumption patterns. By tracking participants over more than two decades with regularly updated dietary data, the researchers produced results that carried substantially more statistical weight than earlier, shorter-term analyses.
The study also produced an unexpected finding regarding sugar-sweetened beverages. Men who consumed one or more regular sodas per day showed a 66 percent increase in non-Hodgkin lymphoma risk — a figure that exceeded the risk associated with diet soda consumption. This finding suggested that the health concerns around soda consumption extended beyond artificial sweeteners alone and raised broader questions about the relationship between sweetened beverage intake and cancer development.
The research was published with citations to the original peer-reviewed studies (PMID: 23097267, 16507461, 17805418) for independent verification of the findings and methodology.
